From: Assessment of clinico-epidemiological profile of Hepatocellular carcinoma in the last two decades
Measure | Point 1 | Point 2 | Point 3 |
---|---|---|---|
Total bilirubin (mg. per 100 ml) | < 2 | 2–3 | > 3 |
Serum albumin (g. per 100 ml) | > 3.5 | 3.5–2.8 | < 2.8 |
Ascites | None | Mild | Moderate to marked |
Hepatic encephalopathy | None | Grade 1–2 | Grade 3–4 |
INR | < 1.7 | 1.7–2.3 | > 2.3 |